2014
DOI: 10.1007/s11094-014-1053-3
|View full text |Cite
|
Sign up to set email alerts
|

Antiviral Activity of Fullerene-(Tris-Aminocaproic Acid) Hydrate Against Respiratory Syncytial Virus in HEp-2 Cell Culture

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 9 publications
0
7
0
Order By: Relevance
“…Besides HIV, the inhibition of viral activity by fullerene derivatives has been tested for hepatitis C virus (HCV), 82 respiratory syncytial virus (RSV), 83 virus H1N1, herpes simplex virus, 84 human cytomegalovirus, 84 Zika and Dengue viruses. 85…”
Section: Fullerenes As Anti-hiv Agentsmentioning
confidence: 99%
“…Besides HIV, the inhibition of viral activity by fullerene derivatives has been tested for hepatitis C virus (HCV), 82 respiratory syncytial virus (RSV), 83 virus H1N1, herpes simplex virus, 84 human cytomegalovirus, 84 Zika and Dengue viruses. 85…”
Section: Fullerenes As Anti-hiv Agentsmentioning
confidence: 99%
“…The radioprotection of this type of blood cells is a highly important task for national health services, particularly for the protection of cancer patients routinely undergoing radiotherapy as a vital component of anticancer treatment. Moreover, the antiviral potential of EACA would be also beneficial for application in oncological clinics [32,114]. It is well known that chemotherapy causes the suppression of the immune system, thus increasing the risk of viral infections that predominantly attack the respiratory tract [115,116].…”
Section: Discussionmentioning
confidence: 99%
“…Fullerene-(tris-aminocaproic acid) hydrate was designed, and their activity against the respiratory syncytial virus was studied [ 122 ]. Fullerene modified with thiosialosyl-a (2,6)-galactose disaccharide was synthesized and investigated for interaction with influenza viral proteins HA and NA.…”
Section: Nanocarriers For Delivery Of Antiviral Agentsmentioning
confidence: 99%